JP2003524462A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003524462A5 JP2003524462A5 JP2000608939A JP2000608939A JP2003524462A5 JP 2003524462 A5 JP2003524462 A5 JP 2003524462A5 JP 2000608939 A JP2000608939 A JP 2000608939A JP 2000608939 A JP2000608939 A JP 2000608939A JP 2003524462 A5 JP2003524462 A5 JP 2003524462A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- energy
- glucose
- analysis device
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001519 tissues Anatomy 0.000 description 97
- 238000004458 analytical method Methods 0.000 description 68
- 239000000126 substance Substances 0.000 description 61
- 230000004913 activation Effects 0.000 description 56
- 239000012530 fluid Substances 0.000 description 54
- 239000000463 material Substances 0.000 description 52
- 238000006243 chemical reaction Methods 0.000 description 47
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 45
- 229960001031 Glucose Drugs 0.000 description 44
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 44
- 239000008103 glucose Substances 0.000 description 42
- 230000003287 optical Effects 0.000 description 37
- 239000003365 glass fiber Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 17
- 238000001514 detection method Methods 0.000 description 15
- 239000000975 dye Substances 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 102000021152 glucose binding proteins Human genes 0.000 description 13
- 108091010154 glucose binding proteins Proteins 0.000 description 13
- 239000000835 fiber Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 230000001464 adherent Effects 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 229940088598 Enzyme Drugs 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 9
- 210000004369 Blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000004366 Glucose oxidase Substances 0.000 description 6
- 229910052721 tungsten Inorganic materials 0.000 description 6
- 239000010937 tungsten Substances 0.000 description 6
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Ampyrone Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001678 irradiating Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- -1 tungsten halogen Chemical class 0.000 description 5
- PHOLIFLKGONSGY-NTMALXAHSA-N (Z)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2S\C(=N/N)N(C)C2=C1 PHOLIFLKGONSGY-NTMALXAHSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 108010015776 EC 1.1.3.4 Proteins 0.000 description 4
- 210000003722 Extracellular Fluid Anatomy 0.000 description 4
- 229940116332 GLUCOSE OXIDASE Drugs 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- 230000001070 adhesive Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 229940072417 Peroxidase Drugs 0.000 description 3
- 108090000437 Peroxidases Proteins 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 230000001809 detectable Effects 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 2
- LHZMSRLULDAWLM-UHFFFAOYSA-N 3-(N-ethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC=C1 LHZMSRLULDAWLM-UHFFFAOYSA-N 0.000 description 2
- FEPBITJSIHRMRT-UHFFFAOYSA-M 4-hydroxybenzenesulfonate Chemical compound OC1=CC=C(S([O-])(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-M 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N ABTS Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 2
- 206010012601 Diabetes mellitus Diseases 0.000 description 2
- 229940096919 Glycogen Drugs 0.000 description 2
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 102000005548 Hexokinases Human genes 0.000 description 2
- 108020002022 Hexokinases Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000001588 bifunctional Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000002875 fluorescence polarization Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- KJUGUADJHNHALS-UHFFFAOYSA-O hydron;2H-tetrazole Chemical compound C1=NN=[NH+]N1 KJUGUADJHNHALS-UHFFFAOYSA-O 0.000 description 2
- 239000005414 inactive ingredient Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XDIYNQZUNSSENW-NUVHGKSTSA-N (2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanal;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-NUVHGKSTSA-N 0.000 description 1
- WYFYSTBFFDOVJW-UHFFFAOYSA-L 2-[4-[4-(3,5-diphenyltetrazol-2-ium-2-yl)phenyl]phenyl]-3,5-diphenyltetrazol-2-ium;dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC(=CC=2)C=2C=CC(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=NN1C1=CC=CC=C1 WYFYSTBFFDOVJW-UHFFFAOYSA-L 0.000 description 1
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 2-hydroxy-3-morpholin-4-ium-4-ylpropane-1-sulfonate Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-Tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- CDGBQMHYFARRCC-UHFFFAOYSA-N 3-(N-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 CDGBQMHYFARRCC-UHFFFAOYSA-N 0.000 description 1
- ZTQGWROHRVYSPW-UHFFFAOYSA-N 3-(N-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZTQGWROHRVYSPW-UHFFFAOYSA-N 0.000 description 1
- CLEVULOKVPBHCU-UHFFFAOYSA-N 3-anilino-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CNC1=CC=CC=C1 CLEVULOKVPBHCU-UHFFFAOYSA-N 0.000 description 1
- VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 239000007988 ADA buffer Substances 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 239000007992 BES buffer Substances 0.000 description 1
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N Benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N Bis-tris methane Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N Bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 229940098773 Bovine Serum Albumin Drugs 0.000 description 1
- 108091003117 Bovine Serum Albumin Proteins 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M Dioctyl sodium sulfosuccinate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229960000878 Docusate Sodium Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 210000003811 Fingers Anatomy 0.000 description 1
- OINNEUNVOZHBOX-QIRCYJPOSA-N Geranylgeranyl pyrophosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-QIRCYJPOSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N MOPS Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 229920002521 Macromolecule Polymers 0.000 description 1
- 210000004379 Membranes Anatomy 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 description 1
- 229940052665 NADH Drugs 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L Nitro blue tetrazolium chloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 229940051841 POLYOXYETHYLENE ETHER Drugs 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 210000003240 Portal Vein Anatomy 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 239000007994 TES buffer Substances 0.000 description 1
- 210000003813 Thumb Anatomy 0.000 description 1
- FPKOPBFLPLFWAD-UHFFFAOYSA-N Trinitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1[N+]([O-])=O FPKOPBFLPLFWAD-UHFFFAOYSA-N 0.000 description 1
- LWZFANDGMFTDAV-URHIDPGUSA-N [(2R)-2-[(3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-URHIDPGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000005260 alpha ray Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical class [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- BPYKTIZUTYGOLE-IFADSCNNSA-N bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 102000024070 binding proteins Human genes 0.000 description 1
- 108091007650 binding proteins Proteins 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000003260 fluorescence intensity Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- YCMNFTXISHKEBZ-UHFFFAOYSA-N iodonitrotetrazolium Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C=CC=CC=2)=N1 YCMNFTXISHKEBZ-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000001795 light effect Effects 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004880 lymph fluids Anatomy 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 230000003595 spectral Effects 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12744299P | 1999-04-01 | 1999-04-01 | |
US60/127,442 | 1999-04-01 | ||
PCT/US2000/008530 WO2000059371A1 (en) | 1999-04-01 | 2000-03-31 | Dual function assay device |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003524462A JP2003524462A (ja) | 2003-08-19 |
JP2003524462A5 true JP2003524462A5 (zh) | 2004-12-24 |
Family
ID=22430139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000608939A Pending JP2003524462A (ja) | 1999-04-01 | 2000-03-31 | 2機能分析デバイス |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1164923A1 (zh) |
JP (1) | JP2003524462A (zh) |
AU (1) | AU4054000A (zh) |
BR (1) | BR0009468A (zh) |
CA (1) | CA2366746A1 (zh) |
MX (1) | MXPA01009830A (zh) |
WO (1) | WO2000059371A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003226605A1 (en) | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
US7787923B2 (en) * | 2003-11-26 | 2010-08-31 | Becton, Dickinson And Company | Fiber optic device for sensing analytes and method of making same |
EP2200666B1 (en) | 2007-10-09 | 2014-12-03 | Syneron Medical Ltd. | Magnetic patch coupling |
JP5612474B2 (ja) | 2007-10-17 | 2014-10-22 | トランスファーマ メディカル リミテッド | 溶出速度の検証 |
CN101969873B (zh) | 2007-12-05 | 2015-05-13 | 赛诺龙医疗公司 | 一次性电磁能施用器以及使用它的方法 |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
US9354226B2 (en) | 2009-12-17 | 2016-05-31 | Ascensia Diabetes Care Holdings Ag | Transdermal systems, devices, and methods to optically analyze an analyte |
US20120252046A1 (en) | 2009-12-17 | 2012-10-04 | Bayer Healthcare Llc | Transdermal systems, devices, and methods for biological analysis |
US20170135637A1 (en) * | 2014-07-31 | 2017-05-18 | Empire Technology Development Llc | Real-time glucose monitoring |
CN107928681B (zh) * | 2017-12-12 | 2020-07-21 | 天津大学 | 一种基于耳垂血液层的微波能量谱无创血糖浓度检测法 |
CN112972884B (zh) * | 2021-03-18 | 2021-12-10 | 河南省肿瘤医院 | 一种肿瘤科用智能敷药装置 |
GB202110716D0 (en) * | 2021-07-26 | 2021-09-08 | Ams Sensors Singapore Pte Ltd | Optical flow sensor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5792049A (en) | 1996-01-17 | 1998-08-11 | Spectrx, Inc. | Spectroscopic system with disposable calibration device |
US6022316A (en) | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
-
2000
- 2000-03-31 MX MXPA01009830A patent/MXPA01009830A/es unknown
- 2000-03-31 JP JP2000608939A patent/JP2003524462A/ja active Pending
- 2000-03-31 WO PCT/US2000/008530 patent/WO2000059371A1/en not_active Application Discontinuation
- 2000-03-31 EP EP00919932A patent/EP1164923A1/en not_active Withdrawn
- 2000-03-31 CA CA002366746A patent/CA2366746A1/en not_active Abandoned
- 2000-03-31 BR BR0009468-4A patent/BR0009468A/pt not_active Application Discontinuation
- 2000-03-31 AU AU40540/00A patent/AU4054000A/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6704587B1 (en) | Dual function assay device | |
US6503198B1 (en) | Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods | |
TWI283570B (en) | Physiological sample collection devices and methods of using the same | |
AU783326B2 (en) | Optical component based temperature measurement in analyte detection devices | |
US6226082B1 (en) | Method and apparatus for the quantitative analysis of a liquid sample with surface enhanced spectroscopy | |
US20100049016A1 (en) | Noninvasive Transdermal Systems for Detecting an Analyte in a Biological Fluid and Methods | |
RU2291667C2 (ru) | Тестирующее устройство, тестирующая полоска, устройство и способ измерения концентрации | |
CA2506942C (en) | Body fluid testing device | |
US6285448B1 (en) | Clinical analyte determination by infrared spectroscopy | |
JPH06104080B2 (ja) | 体液中のグルコ−スの検出方法および検出装置 | |
US20050201897A1 (en) | Body fluid testing device | |
JP2004033759A (ja) | 試験片容器システム | |
JP2003524462A5 (zh) | ||
JP2003524462A (ja) | 2機能分析デバイス | |
JP2005526953A (ja) | エンボス加工されたテストストリップシステム | |
JP2008532020A (ja) | 皮膚組織コレステロールの非侵襲的測定法と器具 | |
AU2002300167B2 (en) | Noninvasive Transdermal Systems for Detecting Analytes | |
US8501111B2 (en) | Small volume and fast acting optical analyte sensor |